A multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Design, Prospective, Phase II Clinical Trial to Evaluate the Safety and Efficacy of GV1001, a novel peptide mimicking human telomerase reverse transcriptase, for the Treatment of Moderate to Severe Alzheimer’s Disease

제목
A multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Design, Prospective, Phase II Clinical Trial to Evaluate the Safety and Efficacy of GV1001, a novel peptide mimicking human telomerase reverse transcriptase, for the Treatment of Moderate to Severe Alzheimer’s Disease
저자
고성호
발행일
2019-12-04
학회명
the 12th edition of Clinical Trials on Alzheimer’s Disease
개최지
San Diego, California, USA